TWC
VIR icon

TD Waterhouse Canada’s Vir Biotechnology VIR Stock Holding History

TD Waterhouse Canada’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30
Closed -$269 – 2505
2026
Q1 		$269 Buy
+30
New +$239 ﹤0.01% 2177
2023
Q3 		– Sell
-100
Closed -$3.25K – 1803
2023
Q2 		$3.25K Hold
100
– – ﹤0.01% 1464
2023
Q1 		$3.13K Hold
100
– – ﹤0.01% 1454
2022
Q4 		$3.41K Hold
100
– – ﹤0.01% 1419
2022
Q3 		$2.72K Hold
100
– – ﹤0.01% 1460
2022
Q2 		$3.34K Buy
+100
New +$2.33K ﹤0.01% 1463

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TD Waterhouse Canada's VIR Position: Q2 2026 in Review

TD Waterhouse Canada sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 30 shares — an estimated $269 sold.

TD Waterhouse Canada first reported a position in VIR in Q2 2022 and held it in 6 quarters. The position peaked at $3.41K in Q4 2022. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • TD Waterhouse Canada reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 30 Vir Biotechnology shares in Q2 2026, an estimated $269.
  • TD Waterhouse Canada first reported a position in Vir Biotechnology in Q2 2022 and held it in 6 quarters.
  • TD Waterhouse Canada's Vir Biotechnology position peaked at $3.41K in Q4 2022.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.